UAE Clinical Nutrition Market Report 2023 to 2030

UAE Clinical Nutrition Market Analysis

$ 3999

The UAE Clinical Nutrition Market was valued at $153.3 Mn in 2023 and is projected to grow at a CAGR of 6.34% from 2023 to 2023, to $235.8 Mn by 2030. The key drivers of this industry are increasing prevalence of chronic diseases and metabolic disorders, aging population, increasing awareness of the importance of nutrition for health, product innovations and technological advancements, government initiatives and rising healthcare expenditure, rising incidence of malnutrition especially in paediatric patients which has contributed to market growth. The industry is primarily dominated by players such as BASF, B Braun, Abbott Nutrition, Pfizer Inc, Bayer AG, Nestle, Baxter International Inc., Otsuka Holdings Co., Ltd among others.

ID: IN10AEPH569 CATEGORY: Pharmaceuticals GEOGRAPHY: UAE AUTHOR: Mahima Reddy

Buy Now

UAE Clinical Nutrition Market Executive Summary

The UAE Clinical Nutrition Market is at around $153.3 Mn in 2023 and is projected to reach $235.8 Mn in 2030, exhibiting a CAGR of 6.34% during the forecast period 2023-2030.

Clinical malnutrition refers to a condition that can be treated with clinical intervention by using specialized nutrients that are considered proper medications rather than as supplements. Clinical nutrition products are useful in maintaining the patient's health and enable the improvement of the body's metabolic system by providing adequate supplements, such as minerals, vitamins, and other supplements. The clinical nutrition sector is undergoing a transformation fuelled by progress in medical research and technology. Key trends such as innovative formulations, personalized nutrition solutions, and the use of bioactive ingredients are emerging. Manufacturers are dedicating resources to R&D to produce products that not only fulfil fundamental nutritional requirements but also provide added health advantages. This emphasis on innovation is fostering competition among industry participants, resulting in a constant flow of new products and therapies tailored to various patient demographics.

Clinical nutritionists or registered dietitians work in hospitals, clinics, and other healthcare facilities to, assess patients' nutritional status, develop personalized nutrition plans, provide nutrition education, manage nutrition-related diseases like diabetes, malnutrition etc, support optimal health and well-being. Some areas of focus in clinical nutrition include, critical care nutrition, paediatric nutrition, oncology nutrition, gastrointestinal nutrition, sports nutrition etc.

The prevalence of chronic disorders in the United Arab Emirates (UAE) has been increasing, largely due to lifestyle factors and rapid urbanization. Obesity and Overweight is highly rising health concern with high prevalence rate, with estimates ranging from 30-40% of the adult population, childhood obesity is also a significant concern. Cardiovascular Diseases, a leading cause of mortality, accounting for about 30% of all deaths. Hypertension affects around 30-35% of adults. The major drivers of Clinical Nutrition industry in UAE are, increasing prevalence of chronic diseases and metabolic disorders, aging population, increasing awareness of the importance of nutrition for health, product innovations and technological advancements, government initiatives and rising healthcare expenditure, rising incidence of malnutrition especially in paediatric patients.

The industry is primarily dominated by players such as BASF, B Braun, Abbott Nutrition, Pfizer Inc, Bayer AG, Nestle, Baxter International Inc., Otsuka Holdings Co., Ltd among others.

UAE Clinical Nutrition Market Report 2023 to 2030

Market Dynamics

Market Drivers

Rising prevalence rate: Increasing prevalence of chronic health diseases like cardiovascular diseases and diabetes Conditions such as heart disease, stroke, and diabetes have become leading causes of death in the UAE. The prevalence of chronic disorders in the United Arab Emirates (UAE) has been increasing, largely due to lifestyle factors and rapid urbanization. Obesity and Overweight is highly rising health concern with high prevalence rate, with estimates ranging from 30-40% of the adult population, childhood obesity is also a significant concern. Cardiovascular Diseases, a leading cause of mortality, accounting for about 30% of all deaths. Clinical nutrition plays a crucial role in the management and treatment of these chronic diseases. The growing burden of these health issues is driving the demand for specialized clinical nutrition products.

Growing aging population with higher nutritional needs: The UAE has an increasing aging population, with a significant proportion of older adults. Older adults often have higher nutritional requirements due to physiological changes and increased risk of chronic diseases. Clinical nutrition products are essential for maintaining the health and well-being of the aging population.

Rising usage of clinical nutrition products in developing countries: The UAE, as a developing country, is experiencing an increase in the usage of clinical nutrition products. Improved healthcare infrastructure, increased awareness, and rising disposable incomes are contributing to this trend. The growing acceptance and adoption of clinical nutrition products in the UAE are driving market expansion.kjhvc

Market Restraints

Lack of awareness: Many people in the UAE are still unaware of the importance of proper nutrition, especially for managing chronic health conditions. Limited education and awareness campaigns on the benefits of clinical nutrition hinder market growth.

Stringent regulatory framework: The UAE has a strict regulatory environment for clinical nutrition products. Registration and approval requirements can be complex and time-consuming for manufacturers. These regulations aim to ensure product safety and efficacy but can also pose challenges for market entry and product development. Thus, hampering the market growth rate.

Prevalence of false perceptions about malnutrition: There are still some misconceptions and false perceptions about malnutrition in the UAE. Some people may not recognize the importance of clinical nutrition or may have inaccurate beliefs about its necessity, which makes it difficult for the market to grow.

Regulatory Landscape and Reimbursement Scenario

Clinical nutrition regulation and reimbursement in the United Arab Emirates (UAE) are managed within a healthcare system that combines public and private sector involvement. The Ministry of Health and Prevention (MOHAP) serves as the primary federal health authority, overseeing healthcare policies and regulations, including those related to clinical nutrition. The UAE Food and Drug Administration, a part of MOHAP, regulates food safety, drugs, and medical devices, including nutritional products. Additionally, individual emirates have their own health authorities, such as the Dubai Health Authority and the Department of Health Abu Dhabi, which play significant roles in healthcare regulation and service provision. Pharmaceutical regulation, including products used in clinical nutrition, falls under the purview of the UAE FDA, which oversees registration, licensing, and quality control.

The reimbursement system in the UAE is mixed, with Emirati citizens receiving free or heavily subsidized healthcare, including clinical nutrition services, through government facilities. For residents, health insurance is mandatory in emirates like Dubai and Abu Dhabi, with employers required to provide coverage. Insurance plans typically cover medically necessary nutritional interventions, including enteral and parenteral nutrition, when prescribed by a physician, though coverage for outpatient nutritional counselling and dietary supplements can vary depending on the specific plan. The UAE has been focusing on preventive healthcare, including nutritional interventions to address issues like obesity and diabetes, and there's an increasing emphasis on integrating nutritional counselling into primary healthcare services. The country is also investing in medical tourism, offering advanced nutritional therapies in specialized centres.

Competitive Landscape

Key Players

Here are some of the major key players in the UAE Clinical Nutrition Market:

B Braun
BASF
Zydus Healthcare LLC
Abbott Nutrition
Gulf Pharmaceuticals
Pfizer Inc.
Bayer AG
Nestle
Baxter International Inc.
Otsuka Holdings Co., Ltd

1. Executive Summary
1.1 Disease Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Patient Journey
1.6 Health Insurance Coverage in Country
1.7 Active Pharmaceutical Ingredient (API)
1.8 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Epidemiology of Disease
2.2 Market Size (With Excel & Methodology)
2.3 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

UAE Clinical Nutrition Market Segmentation

By Product

Oral Clinical Nutrition
Parenteral Nutrition
Carbohydrates
Parenteral Lipid Emulsion
Single Dose Amino Acid Solutions
Trace Elements
Vitamins & Minerals
Enteral Feeding Formulas
Standard Formula
Disease-specific Formulas
Others

By Application

Alzheimer’s Disease
Nutrition Deficiency
Cancer Care
Diabetes
Chronic Kidney Diseases
Orphan Diseases
Dysphagia
Pain Management
Malabsorption/GI Disorder/Diarrhea
Others

By Sales Channel

Retail Sales Channels
Online Sales Channels
Institutional Sales Channels
Others

End Users

Geriatric
Adults
Paediatric

Methodology for Database Creation

Our database offers a comprehensive list of healthcare centers, meticulously curated to provide detailed information on a wide range of specialties and services. It includes top-tier hospitals, clinics, and diagnostic facilities across 30 countries and 24 specialties, ensuring users can find the healthcare services they need.

Additionally, we provide a comprehensive list of Key Opinion Leaders (KOLs) based on your requirements. Our curated list captures various crucial aspects of the KOLs, offering more than just general information. Whether you're looking to boost brand awareness, drive engagement, or launch a new product, our extensive list of KOLs ensures you have the right experts by your side. Covering 30 countries and 36 specialties, our database guarantees access to the best KOLs in the healthcare industry, supporting strategic decisions and enhancing your initiatives.

How Do We Get It?

Our database is created and maintained through a combination of secondary and primary research methodologies.

1. Secondary Research

With many years of experience in the healthcare field, we have our own rich proprietary data from various past projects. This historical data serves as the foundation for our database. Our continuous process of gathering data involves:

Analyzing historical proprietary data collected from multiple projects.
Regularly updating our existing data sets with new findings and trends.
Ensuring data consistency and accuracy through rigorous validation processes.

With extensive experience in the field, we have developed a proprietary GenAI-based technology that is uniquely tailored to our organization. This advanced technology enables us to scan a wide array of relevant information sources across the internet. Our data-gathering process includes:

Searching through academic conferences, published research, citations, and social media platforms
Collecting and compiling diverse data to build a comprehensive and detailed database
Continuously updating our database with new information to ensure its relevance and accuracy

2. Primary Research

To complement and validate our secondary data, we engage in primary research through local tie-ups and partnerships. This process involves:

Collaborating with local healthcare providers, hospitals, and clinics to gather real-time data.
Conducting surveys, interviews, and field studies to collect fresh data directly from the source.
Continuously refreshing our database to ensure that the information remains current and reliable.
Validating secondary data through cross-referencing with primary data to ensure accuracy and relevance.

Combining Secondary and Primary Research

By integrating both secondary and primary research methodologies, we ensure that our database is comprehensive, accurate, and up-to-date. The combined process involves:

Merging historical data from secondary research with real-time data from primary research.
Conducting thorough data validation and cleansing to remove inconsistencies and errors.
Organizing data into a structured format that is easily accessible and usable for various applications.
Continuously monitoring and updating the database to reflect the latest developments and trends in the healthcare field.

Through this meticulous process, we create a final database tailored to each region and domain within the healthcare industry. This approach ensures that our clients receive reliable and relevant data, empowering them to make informed decisions and drive innovation in their respective fields.